Press release
Gene Panel Market Fueled by 19.6% CAGR and Rising Demand for Precision Oncology Diagnostics
Gene Panel Market
The Gene Panel Market focuses on diagnostic tests that simultaneously analyze multiple genes for cancer-associated mutations, such as BRCA1 and BRCA2, which produce tumor-suppressing proteins to repair damaged DNA. These panels are critical for applications like cancer risk assessment, syndrome-specific diagnostics, and disease penetration analysis, serving biotechnology companies, diagnostic laboratories, and research institutes.
📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):
https://www.datamintelligence.com/download-sample/gene-panel-market?sindhuri
☛ Gene Panel Market Forces Driving Future Growth
The gene panel market is driven by the rising prevalence of chronic diseases, with chronic diseases expected to account for 73% of global deaths by 2020, per WHO, including cancer, cardiovascular diseases, chronic obstructive pulmonary disease, and diabetes. The growing adoption of gene panels for their superior diagnostic yield, particularly for hereditary breast and ovarian cancers, boosts demand. Technological advancements in diagnostics, such as next-generation sequencing (NGS), and strategic collaborations like QIAGEN's partnership with INOVIO for cervical dysplasia diagnostics, further propel growth.
Challenges include security concerns over genetic data, which is unique and irreplaceable, increasing risks of data breaches and limiting adoption in healthcare and R&D. The COVID-19 pandemic also disrupted genetic testing by hindering access to blood draws, reducing demand for gene panels.
Opportunities lie in the growing demand for personalized medicine, particularly in North America, and the expansion of NGS-based diagnostic kits. Emerging markets in Asia-Pacific, driven by increasing chronic disease burdens and healthcare investments, offer significant growth potential.
☛ Gene Panel Industry News
Partnerships: In April 2021, Illumina and Kartos Therapeutics partnered to develop an NGS-based TP53 companion diagnostic for hematologic malignancies. In October 2019, QIAGEN and Illumina signed a 15-year partnership to enhance NGS-based in-vitro diagnostic (IVD) kits for patient care.
Collaborations: The Ethiopian Biotechnology Institute (EBTi) and BGI Health Ethiopia signed an MoU for an HPV Genotyping Pilot Project, advancing technological relations.
Product Innovations: Thermo Fisher Scientific launched the Ion AmpliSeq Hybridization-based technology in June 2018, improving the accuracy of sequencing by hybridization.
☛ Gene Panel Market: Industry Giants and Emerging Leaders
» Illumina, Inc.
» Thermo Fisher Scientific
» Agilent Technologies
» QIAGEN
» BGI (China)
» Eurofins Scientific
» Novogene Corporation (China)
» F. Hoffmann-La Roche AG
» Integrated DNA Technologies
» Genewiz, Inc.
Research Methodology
Our research methodology integrates qualitative and quantitative approaches to deliver reliable market intelligence. We conduct thorough secondary research using trusted industry publications, proprietary databases, and credible market sources, complemented by primary research involving structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/gene-panel-market
☛ Segments Covered in the Gene Panel Market
By Product & Service
Test Kits dominate due to their widespread use in research and diagnostics for understanding genetic variability in chronic diseases. Other segments include Reagents, Software, and Services.
By Technique
Hybridization-Based Approach leads, driven by advancements like Thermo Fisher's Ion AmpliSeq technology, improving accuracy in sequencing. Other techniques include Amplicon-Based Approach and Others.
By Design
Predesigned Gene Panels and Customized Gene Panels cater to specific diagnostic and research needs, with predesigned panels holding a larger share due to standardized applications.
By Application
Cancer Risk Assessment dominates, followed by Syndrome-Specific Diagnostics, Disease Penetration, and Others, driven by the rising cancer burden and need for precise diagnostics.
By End User
Biotechnology Companies and Diagnostic Laboratories lead due to high demand for genetic testing, followed by Research Institutes and Others.
☛ This Report Covers
✔ Go-to-market Strategy.
✔ Neutral perspective on market performance.
✔ Development trends, competitive landscape analysis, supply-side analysis, demand-side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analyses.
✔ Customized regional/country reports as per request and country-level analysis.
✔ Potential & niche segments and regions exhibiting promising growth.
✔ Top-down and bottom-up approach for regional analysis.
📌 Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=gene-panel-market
☛ Regional Analysis for Gene Panel Market
⇥ North America (U.S., Canada, Mexico) - Dominates due to high demand for personalized medicine, advanced genetic testing technologies, and rising cancer cases (e.g., 1.9 million new cases in the U.S. in 2022).
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands, Rest of Europe) - Growing due to research advancements and oncology applications.
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia, Rest of Asia Pacific) - Fastest-growing region, driven by increasing chronic disease prevalence and healthcare investments.
⇥ South America (Colombia, Brazil, Argentina, Rest of South America) - Emerging market with growing genetic testing adoption.
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) - Steady growth supported by expanding healthcare infrastructure.
📌 Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription
☛ Power Your Decisions with Real-Time Insights
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We leverage our top trademark trends, insights, and developments to deliver swift and astute solutions to clients. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Panel Market Fueled by 19.6% CAGR and Rising Demand for Precision Oncology Diagnostics here
News-ID: 4174123 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.
Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional…
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031.
Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The…
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031).
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric…
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
